Clinical Group

International Journal of Immunotherapy and Cancer Research

ISSN: 2455-8591



About International Journal of Immunotherapy and Cancer Research

Journal Information
  • Volume/IssueClick here
  • Review ProcessDouble Blind
  • Publication lead time3 - 4 weeks
  • Indexing statusYes; Purview
  • Manuscript Processing ChargesClick here
  • Submission ChargesNo
  • Waiver policy for APCYes
  • Language of Full TextEnglish
  • Full-text formats availablePDF, HTML
Best Practices
  • Type of LicenseCreative Commons
  • Open AccessYes; Policy
  • Does the author retain unrestricted copyright?Yes
  • Does the author retain publishing rights?Yes
  • Permanent article identifierDOI (Digital Object Identifier)


International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health

Read more

Editorial Board

Karin Schroten-Loef
Integraal Kankercentrum Nederland

 Research interests: Carcinoma Unknown Primary Cancer of Unknown Primary (CUP) is the term applied to metastatic cancer of which the origin remains unidentified. Since treatment is usually based on the profile of the primary cancer, treatment of these patients is a challenge. Reports on incidence, treatment, and survival are limited. My personal challenge is to increase the awareness with regard to CUP via research and support patients suffering from CUP, as well as the patients' family and friends. Prostate cancer. Prostate cancer is a disease of elderly males. An increase in prostate cancer is expected in the coming years due to a growing population of men aged over 60 years of age from 475 million in 2009 to 1.6 billion in the year 2050 worldwide. Moreover, if screening for prostate cancer is taken into account, even more men will be diagnosed with this disease. Immunotherapy, especially the role of Interleukin 7 and TGFbeta

Mayordomo Jose Ignacio
University of Colorado

Research Interest: Cancer immunotherapy, antigen presentation, dendritic cells, costimulatory molecule AND cancer vaccine.

D Sugapriya
Assistant Professor
Department of Medical Lab Sciences
Prince Sattam Bin Abdullaziz University
Saudi Arabia

Research Interest: Immunophenotyping, Immunocytochemistry, Multilineag differentiation, RNA isolation, RT- PCR, Cancer cell line, Immunocytochemistry, Real-Time PCR, Western blot, Transport mechanism by liquid santillation Counter, Induction of leukemia in experimental animal, Biochemical enzymatic analysis, TEM analysis, Histopathology, RT-PCR, apoptosis analysis, Western blot, MTT assay, Measurement of intracellular ROS, Analysis of mitochondrial membrane potential, Intracellular calcium levels, Quantification of endogenous GSH, DNA fragmentation, Column Chromatography, Antibiotic sensitivity assay, Extract preparation, Antibiotic sensitivity assay

David R. Minor
California Pacific Center for Melanoma Research and Treatment

Research Interest: Melanoma, kidney cancer , immunotherapy with ipilimumab, nivolumab, interleukin-2 and other agents. 

LV Rao
Department of Clinical Pathology
UMass Memorial Health Care

Research Interest: Lab Medicine, Clinical Chemistry, Endocrinology and Immunology.

Houria Boulaiz Tassia
Department of Human Anatomy and Embryology
University of Granada

Research Interest: Cancer therapy, cancer stem cells, tumour biomarkers, suicide gene therapy and antitumoral drugs, nanotechnology and regenerative medicine.

Kavindra P Singh
Research Scholar
Department of Nuclear Medicine
BBA Central University

Research Interest: Cancer biology, Cell culture, and Molecular biology

Emmanuel Enoch Kwaku
School of Life Sciences
University of Science and Technology of China

Research Interest: RNA interefence, Immunotherapy and Immunodiagnostics

Neetu Singh
Assistant Professor
Advanced Molecular Science Research Centre
King Georges Medical University

Research Interest: Cancer Genomics and Transcriptomics, Mesenchymal Stem cell culture, characterization and profiling from various sources, in vitro and ex-vivo human breast cancer explants, drug screening in in vitro system.

Maurizio Chiriva Internati
Associate Professor
Department of Internal Medicine
University Texas Health Sciences Center

Research Interest: These cancers express unique tumor-specific or -associated antigens to which my lab directs T cell immune responses via DNA, RNA, protein or peptide based vaccines.  Vaccine components are delivered in their native form, by dendritic cells, by recombinant Adeno Associated Virus.  This clinically translational research is backed up by pre-clinical and basic research in both normal and transgenic animal models and in laboratory studies on patient material. Results from the pre-clinical studies have led to a variety of clinical trials for which I am the immunological coordinator. 

Constantinos Giaginis
Assistant Professor
Department of Food Science & Nutrition
University of Aegean

Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles

Guozheng Liu
Associate Professor
Department of Radiology
University of Massachusetts Medical Schoo

Research Interest: Radiopharmaceutical development that involves radiolabeled agents and their evaluations both in vitro and in vivo. These agents are for disease detection, life process tracing, or tumor radiotherapy.

Khor Goot Heah
Faculty of Dentistry
Universiti Teknologi Mara

Research Interest: Oral Sciences, Oral Pathology, Molecular Biology, Cancer Biology, Histochemistry

Romeo-Gabriel Mihaila
Faculty of Medicine of Lucian Blaga
University of Sibiu, Romania

Research Interest: Leukemia and lymphoma – clinical aspects,  Adjuvant treatments in malignant hemopathies (e.g. resveratrol, statins), Connections between malignant hemopathies and dyslipidemia or metabolic syndrome, Thrombin generation in malignant hemopathies

Fei Tang
Research Associate
Center for Cancer and Immunology Research
Childrens National Medical Center

Research Interest: 1) mTOR signaling, inflammation and hematopoiesis; (2) Neoplasm, hematologic cancers and related disorders; (3) Experimental cancer biology and clinical oncology; (4) Molecular mechanisms regulating hematopoietic stem cells function; (5) Molecular mechanisms involved in T / B / myeloid/erythroid cells developments; (6) Ubiquitination, apoptosis and selective autophagy.

View more

A Very Rare Case of Polycythemia Vera Patient Who Developed Other Four Cancers

Published On: February 03, 2017 | Pages: 012 - 014

Author(s): Romeo-Gabriel Mihaila*
View Article DOI: 10.17352/2455-8591.000013

Immunosuppressive and Cytotoxic Potential of Flavonoids from Medicinal Plants: Preliminary Investigation for Anticancer Activity

Published On: February 01, 2017 | Pages: 007 - 011

Author(s): Amit Gupta* and Revati N Chavan
View Article DOI: 10.17352/2455-8591.000012

Dalton’s Lymphoma as a Murine Model for Understanding the Progression and Development of T-Cell Lymphoma and Its Role in Drug Discovery

Published On: February 01, 2017 | Pages: 001 - 006

Author(s): Raj Kumar Koiri*, Aditi Mehrotra and Surendra Kumar Trigun
View Article DOI: 10.17352/2455-8591.000011

Significance of Cancer Stem Cells in Anti-Cancer Therapies

Published On: December 31, 2016 | Pages: 014 - 016

Author(s): Mónica Botelho* and Helena Alves
View Article DOI: 10.17352/2455-8591.000010

A Synchronous Presentation of AITL with Adenocarcinoma of Lung

Published On: October 06, 2016 | Pages: 011 - 013

Author(s): Kanagaraja Karunakaran Parathan*
View Article DOI: 10.17352/2455-8591.000009

Cytokine Production and Human Cytomegalovirus Load in Allogeneic Hematopoietic Stem Cell Transplantation Outcome

Published On: June 17, 2016 | Pages: 003 - 010

Author(s): TA Silva**, JF Correia-Silva, RG Resende, MHNG Abreu, AL Teixeira, H Bittencourt, RS Gomez
View Article DOI: 10.17352/2455-8591.000008

Endothelial Progenitor Cells in Breast Cancer

Published On: January 23, 2016 | Pages: 001 - 002

Author(s): Monica C Botelho*, Helena Alves
View Article DOI: 10.17352/2455-8591.000007

Anti-VEGF Therapy Induces Proteinuria through Endothelial Disorganization Leading to Nephrin Decrease in Podocytes

Published On: October 28, 2015 | Pages: 021 - 028

Author(s): Marianne Terrasse*, Florence Jouan, Thibault Dolley-Hitze, Yannick Arlot-Bonnemains, Marc-Antoine Belaud-Rotureau, Nathalie Rioux-Leclercq, Nolwenn Lorcy, Cécile Vigneau
View Article DOI: 10.17352/2455-8591.000006

Probiotics and Bone Health: It takes GUTS to Improve Bone Density

Published On: October 13, 2015 | Pages: 018 - 022

Author(s): Rupesh K Srivastava*, Hamid Yousf, Geetanjali B Tomar
View Article DOI: 10.17352/2455-8591.000005

N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer

Published On: September 03, 2015 | Pages: 013 - 017

Author(s): Raj Kumar Koiri*, Aditi Mehrotra
View Article DOI: 10.17352/2455-8591.000004